Guangde has been the Editor of BMC Clinical Pathology since 2018 and is based in the Shanghai office. Before joining BioMed Central, Guangde received his BSc in theoretical physics from Nanjing University, China and his PhD in quantum chemistry from the Royal Institute of Technology, Sweden. When he was graduated, he came back to China as an assistant researcher investigating the growth of composite membranes for water processing, before moving on to study the growth of solid tumors using computer simulation. His interest then turned to medial science and he worked as medical editor for a number of years before joining BioMed Central as an editor of BMC series.
Rui Henrique received his MD from the Abel Salazar Institute of Biomedical Sciences of the University of Porto (ICBAS-UP) in 1992. In 2001, after completing a residency in Anatomic Pathology at the Portuguese Oncology Institute of Porto (IPO-Porto), subspecializing in Hematopathology and Uropathology, he became an attending pathologist. In 2006 he became Director of the Department of Pathology. He received his Ph.D. in Medical Sciences (Molecular Pathology) from ICBAS-UP (2006), in cooperation with Johns Hopkins University, USA. In 2011, he obtained the academical title of “Aggregate” in Pathology and Molecular Genetics (ICBAS-UP). He is an invited Full Professor of Pathology and Oncobiology at ICBAS-UP. His research interests focus on the characterization of epigenetic alterations in urological cancer and their translation into novel cancer biomarkers. He has authored and co-authored more than 170 publications in international peer-reviewed scientific periodicals. He joined the Editorial Board of BMC Clinical Pathology in 2014.
Ferdinando Mannello received a degree in Biology in 1982 and a specialization in Clinical Biochemistry in 1999 at the University “Carlo Bo” of Urbino. He completed fellowships in the USA (2005-9) and in the UK (2010). Since 2015, he has been Associate Professor of Clinical Biochemistry and Director of Clinical Biochemistry and Molecular Genetics at the Department of Biomolecular Sciences at the University of Urbino. He is also the chair of Clinical Biochemistry at the School of Biotechnology. His work focuses on clinical translational research of disease biomarkers. Since 2015, he has been responsible for the Biomolecular Diagnostic Committee of the Italian Society of Vascular Diagnostics (SIDV). He has authored over 140 papers as well as book chapters and has been invited to lecture at several international conferences. He has served on the board of BMC Clinical Pathology since 2013.